CSI Market
Sign In | Register

Novabridge Biosciences (NBP) Annual Balance Sheets

Annual · GAAP · USD millions
Access NBP quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Novabridge Biosciences adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent210.63
Cash, Cash Equivalents Other0.00
Restricted Cash0.00
Short-term Investments, Total0.21
Cash & Short-term Investments210.00
Accounts receivable0.00
Other Receivables0.01
Inventories0.00
Discontinued Operations0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current6.68
Total Current Assets217.52
Equipment/Property/Plant Net0.14
Goodwill net0.00
Intangible Assets0.00
Long-term investments0.00
Discontinued operations, Noncurrent0.00
Other Assets, Noncurrent42.86
Restricted Cash Current-
Contract With Customer Asset Net Current-
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset2.81
Total Assets260.52
Liabilities
Accounts Payable and Accrued Liabilities, Current LI16.82
Accrued Liabilities, Current2.78
Short-term Debt0.00
Other Liabilities, Current9.18
Discontinued Operation, Liabilities0.00
Total Current Liabilities26.89
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.66
Discontinued Operation, Noncurrent0.00
Other liabilities, Noncurrent0.51
Contract With Customer Liability Current-
Operating Lease Liability Current0.89
Put Right Liabilities-
Operating Lease Liability Noncurrent2.18
Total Liabilities29.58
Stockholders' Equity
Treasury Stock Common Value-5.04
Common Stock Value0.03
Additional Paid In Capital Common Stock1,526.72
Retained Earnings / Accumulated Deficit-1,332.31
Accumulated Other Comprehensive Income41.55
Other Equity41.55
Common Stockholder's Equity273.01
Total Stockholder's Equity230.94
Liabilities & Stockholder's Equity260.52
4 historic quarters locked

Sign in to unlock the full Novabridge Biosciences balance sheet history.

Sign In Create Free Account

About Novabridge Biosciences Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: April 7, 2026
  • Source: nbp-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001778016-26-000002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License